Alcoholic Intoxication, Chronic
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
577
|
441
|
0.310 |
None |
< 0.001 |
1 |
|
2003 |
2010 |
Mesothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
560
|
4
|
0.310 |
None |
1.000 |
1 |
|
2007 |
2007 |
Alcohol withdrawal syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Disease or Syndrome
|
67
|
6
|
0.310 |
None |
< 0.001 |
1 |
|
2003 |
2003 |
Raynaud Phenomenon
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
63
|
1
|
0.310 |
None |
1.000 |
1 |
|
2006 |
2006 |
Autistic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1112
|
395
|
0.310 |
None |
1.000 |
1 |
|
2006 |
2006 |
Neoplasms, Second Primary
|
phenotype |
Neoplasms
|
Neoplastic Process
|
44
|
2
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Micronuclei, Chromosome-Defective
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell Component
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Dermatologic disorders
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
617
|
21
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Micronuclei, Genotoxicant-Induced
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell Component
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Degenerative Diseases, Spinal Cord
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
40
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Atherogenesis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Treatment related secondary malignancy
|
disease |
Neoplasms
|
Neoplastic Process
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
168
|
11
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Degenerative Diseases, Central Nervous System
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
43
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Chromosome Breaks
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Neoplasms, Therapy-Associated
|
phenotype |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Amphetamine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
75
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Amphetamine Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
2
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Liver neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1424
|
7
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Amphetamine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
78
|
3
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Chromosome Breakage
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
17
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Raynaud Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Drug Allergy
|
group |
Immune System Diseases; Chemically-Induced Disorders
|
Pathologic Function
|
37
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hypotension
|
phenotype |
Cardiovascular Diseases
|
Finding
|
125
|
2
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |